Advisory Board January 6, 2026
Novo Nordisk announced it started rolling out the first-ever GLP-1 pill for weight loss in the United States on Monday. Here’s what you need to know.
Novo Nordisk launches first GLP-1 pill for weight loss
The medication, a Wegovy tablet taken once daily, was approved by FDA in December for both weight loss and cardiovascular risk.
The starting dose of the pill is 1.5 milligrams and is currently available across more than 70,000 U.S. retailers and pharmacies, including CVS and Costco, along with telehealth providers like Ro, LifeMD, Weight Watchers, GoodRx, and Novo Nordisk’s NovoCare Pharmacy. Higher doses of the pill will be available by the end of the week, according to Novo Nordisk.
According to Jason Brett, principal U.S....
Today's Sponsors
Today's Sponsor